Literature DB >> 8816391

Expression of trKB neurotrophin receptor during T cell development. Role of brain derived neurotrophic factor in immature thymocyte survival.

M Maroder1, D Bellavia, D Meco, M Napolitano, A Stigliano, E Alesse, A Vacca, G Giannini, L Frati, A Gulino, I Screpanti.   

Abstract

The relationships between the nervous and the immune systems raise the question of whether neurotrophic factors, in addition to the regulation of neural cell ontogeny, may influence lymphocyte development. We report in this work that the pattern of neurotrophin receptor expression depends on the developmental stage of T cells. The presence of nerve growth factor receptor trkA could not be detected in any of the thymocyte subsets, whereas brain-derived neurotrophic factor (BDNF) receptor trkB was expressed in all thymocyte subpopulations. Interestingly, both trkB mRNA and protein expression inversely correlated with the maturation stage and the differentiation potential of thymocytes, being more expressed in CD4-8- immature thymocytes and progressively declining in CD8+ and CD4+ single-positive and CD4+8+ more mature thymocytes. The developmentally regulated expression of trkB is further shown by the inhibition or enhancement of trkB expression induced by signals that either trigger or impair the transition from immature to more differentiated stages of the thymocyte developmental pathway. Signals generated following the interaction of BDNF with trkB receptor resulted in the stimulation of trkB autophosphorylation and in the up-regulation of the expression of the c-fos gene in CD4-8- cells and enhanced thymocyte survival. Finally, BDNF is expressed in thymic stroma and is further up-regulated by signals generated by the thymocyte/stromal cell interaction. These data suggest that BDNF may be a novel survival factor for thymocyte precursors and support the presence of developmentally regulated feedback mechanisms based on autocrine/paracrine neurotrophin/receptor interactions that may be involved in the thymocyte differentiation process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816391

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

Review 1.  Neurotrophins and the immune system.

Authors:  José A Vega; Olivia García-Suárez; Jonas Hannestad; Marta Pérez-Pérez; Antonino Germanà
Journal:  J Anat       Date:  2003-07       Impact factor: 2.610

2.  Neurotrophins and the thymus: morphological analysis of mice carrying a non-functional mutation on the Trka and Trkb genes.

Authors:  A Germanà; R Laurà; M B Levanti; G Montalbano; G P Germanà; F Abbate; E Ciriaco
Journal:  Vet Res Commun       Date:  2004-08       Impact factor: 2.459

Review 3.  Strategies for reconstituting and boosting T cell-based immunity following haematopoietic stem cell transplantation: pre-clinical and clinical approaches.

Authors:  Ann P Chidgey; Natalie Seach; Jarrod Dudakov; Maree V Hammett; Richard L Boyd
Journal:  Semin Immunopathol       Date:  2008-11-04       Impact factor: 9.623

Review 4.  Implementing neuronal plasticity in NeuroAIDS: the experience of brain-derived neurotrophic factor and other neurotrophic factors.

Authors:  Italo Mocchetti; Alessia Bachis; Lee A Campbell; Valeriya Avdoshina
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-06       Impact factor: 4.147

5.  Expression of the TrkB neurotrophin receptor by thymic macrophages.

Authors:  O García-Suárez; J Hannestad; I Esteban; R Sainz; F J Naves; J A Vega
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

6.  The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain.

Authors:  Elisa Giannini; Roberta Lattanzi; Annalisa Nicotra; Antonio F Campese; Paola Grazioli; Isabella Screpanti; Gianfranco Balboni; Severo Salvadori; Paola Sacerdote; Lucia Negri
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

7.  Repetitive transcranial magnetic stimulation enhances BDNF-TrkB signaling in both brain and lymphocyte.

Authors:  Hoau-Yan Wang; Domenica Crupi; Jingjing Liu; Andres Stucky; Giuseppe Cruciata; Alessandro Di Rocco; Eitan Friedman; Angelo Quartarone; M Felice Ghilardi
Journal:  J Neurosci       Date:  2011-07-27       Impact factor: 6.167

8.  High-affinity neurotrophin receptors and ligands promote leukemogenesis.

Authors:  Zhixiong Li; Gernot Beutel; Mathias Rhein; Johann Meyer; Christian Koenecke; Thomas Neumann; Min Yang; Jürgen Krauter; Nils von Neuhoff; Michael Heuser; Helmut Diedrich; Gudrun Göhring; Ludwig Wilkens; Brigitte Schlegelberger; Arnold Ganser; Christopher Baum
Journal:  Blood       Date:  2008-12-04       Impact factor: 22.113

9.  Intensive Rehabilitation Enhances Lymphocyte BDNF-TrkB Signaling in Patients With Parkinson's Disease.

Authors:  Cecilia Fontanesi; Svetlana Kvint; Giuseppe Frazzitta; Rossana Bera; Davide Ferrazzoli; Alessandro Di Rocco; Heike Rebholz; Eitan Friedman; Gianni Pezzoli; Angelo Quartarone; Hoau-Yan Wang; M Felice Ghilardi
Journal:  Neurorehabil Neural Repair       Date:  2015-08-07       Impact factor: 3.919

10.  HBZ stimulates brain-derived neurotrophic factor/TrkB autocrine/paracrine signaling to promote survival of human T-cell leukemia virus type 1-Infected T cells.

Authors:  Nicholas Polakowski; Marie Terol; Kimson Hoang; Isabelle Nash; Sylvain Laverdure; Hélène Gazon; Gilda Belrose; Jean-Michel Mesnard; Raymond Césaire; Jean-Marie Péloponèse; Isabelle Lemasson
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.